149 related articles for article (PubMed ID: 32110437)
1. The Treatment of Arterial Hypertension.
Brașoveanu AM; Cruce R; Mogoantă L; Cârlig V
Curr Health Sci J; 2019; 45(4):358-365. PubMed ID: 32110437
[TBL] [Abstract][Full Text] [Related]
2. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
[TBL] [Abstract][Full Text] [Related]
3. Effect of fixed-dose ACE-inhibitor/calcium channel blocker combination therapy vs. ACE-inhibitor monotherapy on arterial compliance in hypertensive patients with type 2 diabetes.
Winer N; Folker A; Murphy JA; Hung E; Bard M; Perkelvald A; Sowers JR; Bakris GL
Prev Cardiol; 2005; 8(2):87-92. PubMed ID: 15860983
[TBL] [Abstract][Full Text] [Related]
4. Comparison of health costs associated with treatment of hypertension with a calcium channel blocker and angiotensin-converting enzyme inhibitor in the United States and Japan.
Sakamaki Y; Sasamura H; Ikeda S; Ikegami N; Saruta T
Hypertens Res; 2006 May; 29(5):333-8. PubMed ID: 16832153
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy in hypertension.
Gorostidi M; de la Sierra A
Adv Ther; 2013 Apr; 30(4):320-36. PubMed ID: 23553510
[TBL] [Abstract][Full Text] [Related]
6. PATTERN OF ANTIHYPERTENSIVE THERAPY AMONG DIABETIC HYPERTEN- SIVE PATIENTS IN ZEWDITU MEMORIAL HOSPITAL, ADDIS ABABA.
Abera H; Woldemichael M
Ethiop Med J; 2016 Apr; 54(2):77-82. PubMed ID: 27476227
[TBL] [Abstract][Full Text] [Related]
7. Effects of a fixed-dose ACE inhibitor-diuretic combination on ambulatory blood pressure and arterial properties in isolated systolic hypertension.
Ferguson JM; Minas J; Siapantas S; Komesaroff PA; Sudhir K
J Cardiovasc Pharmacol; 2008 Jun; 51(6):590-5. PubMed ID: 18520951
[TBL] [Abstract][Full Text] [Related]
8. Initial medication selection for treatment of hypertension in an open-panel HMO.
Jerome M; Xakellis GC; Angstman G; Patchin W
J Am Board Fam Pract; 1995; 8(1):1-6. PubMed ID: 7701954
[TBL] [Abstract][Full Text] [Related]
9. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.
Jamerson KA; Nwose O; Jean-Louis L; Schofield L; Purkayastha D; Baron M
Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521
[TBL] [Abstract][Full Text] [Related]
10. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
11. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K
Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280
[TBL] [Abstract][Full Text] [Related]
12. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
JAMA; 2002 Dec; 288(23):2981-97. PubMed ID: 12479763
[TBL] [Abstract][Full Text] [Related]
13. Use of calcium channel blockers and risk of hospitalized gastrointestinal tract bleeding.
Kaplan RC; Heckbert SR; Koepsell TD; Rosendaal FR; Psaty BM
Arch Intern Med; 2000 Jun; 160(12):1849-55. PubMed ID: 10871980
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of combination therapy with angiotensin-converting enzyme inhibitor and calcium channel blocker in hypertension.
Redón J; Trenkwalder PR; Barrios V
Expert Opin Pharmacother; 2013 Feb; 14(2):155-64. PubMed ID: 23194194
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of recent fixed-dose combination therapies in the management of hypertension.
Khanna A; Lefkowitz L; White WB
Curr Opin Nephrol Hypertens; 2008 Sep; 17(5):477-83. PubMed ID: 18695388
[TBL] [Abstract][Full Text] [Related]
16. Fixed low-dose combination of an angiotensin converting enzyme inhibitor and a calcium channel blocker drug in the treatment of essential hypertension.
de Leeuw PW; Kroon AA
J Hypertens Suppl; 1997 Mar; 15(2):S39-42. PubMed ID: 9218197
[TBL] [Abstract][Full Text] [Related]
17. Clinical inquiries. Which combination drug therapies are most effective for hypertension?
Crawford P; Dy D; Carney M
J Fam Pract; 2011 Nov; 60(11):684-6. PubMed ID: 22049354
[TBL] [Abstract][Full Text] [Related]
18. Treating essential hypertension. The first choice is usually a thiazide diuretic.
Prescrire Int; 2014 Sep; 23(152):215-20. PubMed ID: 25325125
[TBL] [Abstract][Full Text] [Related]
19. Manidipine-delapril combination in the management of hypertension.
Otero ML
Vasc Health Risk Manag; 2007; 3(3):255-63. PubMed ID: 17703633
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
